Results 71 to 80 of about 5,476 (161)

Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application

Терапевтический архив, 2010
Antithymocyte immunoglobulins remain to be one of the most effective immunosuppressants used in transplantology and in the treatment of autoimmune diseases. The unique features of the mechanisms of individual antithymocyte globulin preparations should be
A D Kulagin, I A Lisukov, I A Miloserdov, B V Afanasyev   +3 more
doaj  

Anti T-lymphocyte Globulin (Grafalon®) Use during Rabbit Anti-thymocyte Globulin (Thymoglobulin®) Shortage – A Single-center Experience

Indian Journal of Transplantation
Introduction: During a period of local nonavailability of rabbit anti-thymocyte globulin (rATG) in India, anti-T-lymphocyte globulin (ATLG) was utilized in high-risk renal transplantation.
Shailendra Tiwari, Namrata S Rao, Abhilash Chandra, Majibullah Ansari, Sanjeet Kumar Singh   +4 more
doaj   +1 more source

The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients

Pediatric Transplantation, Volume 30, Issue 7, July 2026.
ABPM identified important hypertension phenotypes in pediatric heart transplant recipients. White coat hypertension was common among those with elevated clinic blood pressures and often progressed to ABPM‐confirmed hypertension. Hypertensive patients had higher left ventricular mass, supporting ABPM use for the diagnosis and treatment of hypertension ...
Bushra Anjum, Shannon Oliver, Amira Balbaa, Rae Foshaug, Jennifer Conway, Simon Urschel, Lori J. West, Michael Khoury   +7 more
wiley   +1 more source

Epidemiology and Outcomes of Cryptococcal Infections in Liver Transplant Recipients: A Retrospective Cohort Study at a US Academic Center

Transplant Infectious Disease, Volume 28, Issue 4, July/August 2026.
Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler, Chloe Hanigan, Atikur Rahman, Isuru Ratnayake, Phani Akella, Lauren Carlini, Chelsea Gorsline, Erica Mackenzie, Albert Eid, Dennis Shoemaker, Ryan Taylor, Stephen Waller   +11 more
wiley   +1 more source

Equine Anti-Thymocyte Globulin (ATGAM) administration in patient with previous rabbit Anti-Thymocyte Globulin (Thymoglobulin) induced serum sickness: A case report

, 2018
Thymoglobulin is a rabbit-derived anti-thymocyte antibody directed at T-cells and commonly used for induction immunosuppression therapy in solid organ transplantation, especially in immunologically high risk kidney transplant recipients.
Joseph B Lockridge, Ali J Olyaei, Douglas J Norman, Joseph B Pryor*   +3 more
core   +1 more source

Rabbit-Derived Antithymocyte Globulin-Associated Perioperative Anaphylaxis in Renal Transplantation: A Multidisciplinary Perspective on Pathophysiology, Clinical Presentation, and Management

Antibodies
Rabbit antithymocyte globulin is one of the most commonly used agents for induction immunosuppression in renal transplantation. It has contributed significantly to improved allograft survival and has a favorable safety profile.
Imran Gani, Usman Baig, Ahmad Mirza, Shais Jallu, Abrar Ahad Chawdhary   +4 more
doaj   +1 more source

Terapia de indução com alentuzumabe em receptores de transplante renal Alemtuzumab induction in kidney transplant recipients

Brazilian Journal of Nephrology, 2010
INTRODUÇÃO: Terapias de indução são usualmente utilizadas em receptores sensibilizados contra antígenos HLA, retransplantes e pacientes com risco de apresentar função tardia do enxerto (FTE).
Edison Luiz Mandia Sampaio, Tainá Veras de Sandes Freitas, Nelson Zocoler Galante, Sung In Park, Kelly Miyuki Harada, Filipe Augusto Bettencourt Haolla, Claudia Rosso Felipe, Paul Henri Clesca Troconis, Marcello Fabiano de Franco, Hélio Tedesco Silva Júnior, José Osmar Medina Pestana   +10 more
doaj   +1 more source

Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations

Cell Transplantation, 2020
Post-transplant cyclophosphamide (PTCy) has been explored in several types of stem cell transplantations (SCTs) and it proved highly effective in controlling graft-versus-host disease (GvHD) without aggravating relapsed disease.
Chutima Kunacheewa, Weerapat Owattanapanish, Chutirat Jirabanditsakul, Surapol Issaragrisil   +3 more
doaj   +1 more source

Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation : Application of statistical approaches to reduce bias in observational comparisons

, 2009
Background: Retrospective comparison of treatment-related kidney transplant outcomes may be facilitated by multivariable statistical adjustments and case-matching.
L. M. Willoughby, B. W. Pinsky, N. Dzebisashvili, K. C. Abbott, D. C. Brennan, M. A. Schnitzler, P. M. Buchanan, K. L. Lentine, L.A. Rocca-Rey, L. Neri   +9 more
core   +1 more source

Comparing the effect of immediate versus delayed initiation of tacrolimus on delayed graft function in Kidney transplant recipients: A randomized open-label clinical trial

Journal of Research in Pharmacy Practice, 2018
Objective: Delayed graft function (DGF) is an early complication after kidney transplantation with negative impact on allograft outcomes. This study assessed the effect of delayed initiation of tacrolimus as a nephrotoxic drug, on DGF occurrence and ...
Maryam Ghadimi, Simin Dashti-Khavidaki, Mohammad-Reza Khatami, Mitra Mahdavi-Mazdeh, Mansoor Gatmiri, Farzaneh Sadat Minoo, Neda Naderi, Atefeh Jafari, Mohammad-Reza Abbasi, Ali Ghafari   +9 more
doaj   +1 more source